Table 4.
Approach | Advantages | Disadvantages | Critical content in literatures |
---|---|---|---|
ACDF | Direct removal of anterior pathology; bone graft or cages; maintain cervical disc height and prevent kyphosis | Pseudarthrosis; hardware failure; ASD | 25% of ASD in 10 years |
CDA | Motion preservation; avoidance of non-union; prevention of adjacent segmental degeneration | Ectopic ossification; progressive decrease of neck motion; no long-term follow-up | FDA approved for single- and two-level |
PCF | Minimal invasiveness; avoidance of fusion; preservation of neck motion and ASD; cost effectiveness | Incomplete decompression; deterioration of pathology at index level; facet violation | Improvement in about 90% of patients within a mean follow-up of 10 years |
ACDF, anterior cervical discectomy and fusion; ASD, adjacent segmental disease; CDA, cervical disc arthroplasty; FDA, U.S. Food and Drug Administration; PCF, posterior cervical foraminotomy.